Assistant Professor Chen Hao (center) and PhD student Qiu Zelin (second right) from the School of Engineering, HKUST; Prof. Zhao Yinghua (third left), Dr. Xie Zhuoyao (first right) and other members of the research team from the Third Affiliated Hospital of Southern Medical University.
(From left) Prof. Ma Xiaojuan (HKUST), Prof. Sun Yuling (East China Normal University), and Prof. Tong Xin (Duke Kunshan University) received a Best Paper Award at the ACM CHI Conference 2024.
Two research projects led by Prof. Chau Ying (second from left) are acclaimed at the 48th International Exhibition of Inventions Geneva. One team with Dr. Yu Yu (far right) works on advanced polymer-based therapeutics for chronic disease, while another team with Dr. Melody Chung (far left) and Dr. Laurence Lau (second from right) is developing an artificial cell.
Prof. Chen Hao became one of the 12 inaugural Asian Young Scientist Fellows selected from a large group of highly competitive nominees in Asian region.
(Left) The new technology helps medical staff identify the guidewires by simply taking a photo of all the medical instruments with a smartphone or tablet. (Right) The AI image-based system then could accurately detect guidewires (as indicated by the circle) from other medical instruments using object recognition and data augmentation techniques.
Translational Research Deployed as Clinical Practice
PanopticAI developed an AI health monitoring app using the camera on a smartphone or tablet to monitor the user’s vital signs such as heart rate, respiration rate, blood pressure etc. A pilot scheme has been deployed to 10 to 20 elderly homes across the city.
(From left) Prof. Yeung King-Lun, Director of HKUST-CIL Joint Laboratory of Innovative Environmental Health Technologies (HKUST-CIL Lab); Mr. Hamilton Hung, Chief Marketing Officer of Chiaphua Industries Limited; Prof. Joseph Kwan and Prof. Han Wei, Associate Directors of HKUST-CIL Lab; and a research team member have improved the formula of the antimicrobial coating MAP-1, launched at the onslaught of the COVID-19 pandemic in early 2020, pushing the coating’s durability from three months to five years.
The research team found that despite the number of epitopes encompassing Omicron mutations are nonetheless notably higher than other virus variants, Omicron, like other variants, is still unlikely to escape human's T cell responses.
